Major players in the ENT surgical devices and equipment market are Carl Zeiss Meditec AG, Stryker, Shanghai Fosun Pharmaceuticals Ltd, KLS Martin LP, Acclarent Inc, Medtronic, Smith & Nephew, Boston Scientific, Olympus, and ClaroNav.
New York, May 13, 2022 (GLOBE NEWSWIRE) -- Reportlinker.com announces the release of the report "ENT Surgical Devices And Equipment Global Market Report 2022" - https://www.reportlinker.com/p06277227/?utm_source=GNW
The global ent surgical devices and equipment market is expected to grow from $4.69 billion in 2021 to $5.25 billion in 2022 at a compound annual growth rate (CAGR) of 11.9%. The market is expected to grow to $7.95 billion in 2026 at a compound annual growth rate (CAGR) of 10.9%.
The ENT surgical devices and equipment market consists of sales of ENT (ear-nose-throat) surgical devices. ENT surgical devices include balloon sinus dilation devices, powered surgical instruments, ENT supplies, radiofrequency devices, ear tubes, and handheld instruments are used to perform surgical procedures such as tonsillectomy, tracheostomy, implantations, septorhinoplasty, turbinate reduction, mastoidectomy, stapedectomy, and reconstruction surgeries.
The main products in ENT surgical devices and equipment are hand instruments, ENT surgical lasers, powered ENT surgical systems, radiofrequency electrosurgical devices, ENT surgery workstations, ENT surgical navigation system, ENT visualization system, and surgical microscopes.These devices and equipment are hand-held devices, portable devices, and fixed devices.
The various end-users are hospitals, ambulatory surgical centers, and ENT clinics.
Asia Pacific was the largest region in the ENT surgical devices and equipment market in 2021.North America was the second-largest region in the ENT surgical devices and equipment market.
The regions covered in this report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, the Middle East, and Africa.
Increasing demand and adoption of minimally invasive ENT surgeries will drive the ENT surgical devices and equipment market in the future.For example, minimally invasive ENT surgeries offer patients many benefits such as smaller incisions, faster recovery times, reduced pain, and scarring.
In the majority of the cases, physicians enjoy a higher accuracy rate compared to traditional open surgery. These supreme benefits of minimally invasive ENT surgeries will drive the market.
Lack of proper reimbursement policies for ENT surgical procedures, especially in developing and developed countries, is one of the major factors that could hinder the growth of the ENT surgical devices and equipment market.ENT surgical procedures are complex, involve greater devices, and thus are relatively expensive.
The lack of proper reimbursement policies may inhibit the growth of the ENT surgical devices and equipment market.
ENT procedures involving minimally invasive ENT tools are an alternative to major surgeries.It involves less tissue damage, reduced scarring, and faster recovery thereby leading to greater adoption and would see an increase in the market potential.
Robot-assisted minimally invasive ENT procedures have transformed the treatment landscape of cancer associated with the ear, nose, and throat. For treating benign and malignant conditions of the oropharynx and larynx, Transoral robotic surgery (TORS) is now being widely adopted.
The ENT surgical devices and equipment industry has lately witnessed a rise in the number of FDA clearances which would positively impact the market growth.A pre-market approval by FDA through FDA 510(K) is required for all the medical devices including ENT surgical devices.
As announced by the FDA, the FDA 510(K) is expected to see several updates to regulate safety, technology, and capabilities in the medical devices space.The European Union’s Medical Device Regulation (MDR) presented a few changes that would come into force by 2020.
The changes made to the regulation were in terms of recertification of legacy devices, as well as changes in the definition of regulated devices, safety measures, and risk management.
In 2020, Intersect ENT, a USA-based ear, nose, and throat condition treatment developer, announced to acquire Fiagon for USD 71.1 million. The acquisition was aimed to help Intersect ENT to expand its product portfolio and to extend its geographical reach. Fiagon develops surgical navigation systems that support both routine and complex ENT procedures and is based in Germany.
The countries covered in ENT surgical devices and equipment market are Brazil, China, France, Germany, India, Indonesia, Japan, South Korea, Russia, the UK, the USA, and Australia.
Read the full report: https://www.reportlinker.com/p06277227/?utm_source=GNW
ReportLinker is an award-winning market research solution. Reportlinker finds and organizes the latest industry data so you get all the market research you need - instantly, in one place.
CONTACT: Clare: firstname.lastname@example.org US: (339)-368-6001 Intl: +1 339-368-6001